[ Tips ] 一分鐘使用導覽
商品編號： IN1287 出版日期： 2016/09/26 作者姓名： Chick, Stephen E.;Aggarwal, Ridhima 商品類別： General management 商品規格： 25p 再版日期： 2016/09/26 地域： 產業： Healthcare service industry 個案年度： -
商品敘述：
Sanofi Pasteur''s newly approved dengue vaccine, Dengvaxia, was unusual in that it was launched in the Philippines and other at-risk countries. By choosing to "flip the model" - launch in an emerging market setting as opposed to developed markets - it had to overcome various obstacles across the value chain, from registration to financing to supply. The company spent 20 years and invested $1.7 billion to develop Dengvaxia, taking several high-risk decisions and making trade-offs along the way. The case highlights the stakeholder interdependencies and uncertainties that remained as the vaccine implementation programme crept closer. If successfully resolved, it could potentially offer a blueprint for others.
涵蓋領域：
Healthcare and treatment;Stakeholder relations;Emerging markets;Global health;Public health services;Innovation;Product development;Risk management
相關資料：
, (IN1288), 10p, by Stephen E. Chick, Ridhima Aggarwal
哪些人也有訂購？